Swich CV 100 Dry Syrup

Swich CV 100 Dry Syrup is a combination medicine that contains Cefpodoxime Proxetil and Clavulanic Acid. It is prescribed for the treatment of respiratory tract infections, including those that affect the throat, sinuses, airways, and lungs. This medicine not only treats the existing infection but also helps prevent further spread of harmful bacteria.

It should be taken exactly as advised by the doctor, at a fixed time each day for best results. It can be taken with or without food, but the prescribed dose must not be exceeded. Even if you start to feel better, the full course should be completed to ensure that all bacteria are cleared and to prevent resistance. If a dose is missed, take it as soon as you remember, unless it is almost time for the next one. In that case, skip the missed dose and continue with your regular schedule without doubling it.

Common side effects may include nausea, vomiting, diarrhea, indigestion, headache, abdominal pain, rash, or in some cases vaginal infection. These effects are usually mild and go away as the body adjusts to the medicine. If they persist or worsen, or if you develop an allergic reaction such as itching, swelling, rash, or breathing difficulty, seek medical help immediately.

Before starting this medicine, inform your doctor about any other medications you are taking and any existing health conditions, especially kidney or liver problems. Pregnant and breastfeeding women should consult their doctor before use. Alcohol should be avoided, as it may increase drowsiness. This medicine may sometimes cause dizziness or fits, so you should avoid driving if such symptoms occur.

Swich CV 100 Dry Syrup works by combining two actions. Cefpodoxime Proxetil is an antibiotic that prevents bacteria from forming their protective cell wall, leading to their destruction. Clavulanic Acid is a beta-lactamase inhibitor that blocks bacterial resistance, making Cefpodoxime Proxetil more effective. Together, they ensure better treatment of infections and reduce the chances of bacteria surviving or spreading.

In patients with severe kidney conditions, dose adjustments may be required, so medical supervision is important. For liver-related conditions, safety data is limited and consultation with a doctor is necessary.